Authors

Why the U.S. Pharmaceutical Cold Chain Is Poised for Innovation

Understanding distribution models through prescription capture patterns

This insight piece breaks down how three different specialty pharmacy network structures relate to prescription capture patterns in medically integrated dispensing settings. You’ll learn what distinguishes each type of limited distribution model, how those differences are seen in internal vs. external dispensing behavior, and what the data suggests about the way prescriptions flow across networks. It’s designed to help teams better understand distribution models and think more clearly about how network design may shape dispensing dynamics.

LogiPharma USA 2026: Data Readiness Must Come Before AI

At LogiPharma USA 2026, quality leaders explained why connected data, risk-based prioritization, and human accountability must come before AI in supply chain compliance.

Congress Revives Push to Digitize Prescription Information

New bipartisan legislation would give the FDA authority to modernize prescribing information, reducing waste while improving accuracy and patient care.

2025 Pharma Forecast: Four Pivotal Trends Revolutionizing Market Access Strategies

How AI Control Towers and Digital Twins Can Restore Pharmaceutical Profit Margins

AI-powered control towers and digital twins are emerging as essential tools to prevent costly supply chain failures and restore operational reliability.

Building Agility and Adaptability Into Pharma Operations

Why driving results from such strategies—amid industry disruption—will be critical to success.

How AI-Powered Precision Is Reshaping Medical Affairs

Artificial intelligence is fundamentally transforming medical affairs from a reactive function into a strategic partner.

MFN Program Grows to 26 Drugmakers as Nine More Commit to $19.6B in US Manufacturing

Nine more manufacturers join the MFN program, pairing new Medicaid pricing deals with $19.6B in U.S. manufacturing investment and API reserve donations.

Beyond the Brand Team: Why Every Employee Needs to Be Part of the Journey

Engaging the full workforce—from HR to R&D—can elevate launch outcomes, build trust, and create long-term brand ambassadors.

Forecasting the 2025 Healthcare Logistics Space

How will supply chains in the space continue to develop?

How Smart Packaging and Emerging AI Tools Are Shaping the Future of Cold Chain Integrity

In a video interview with Pharma Commerce, Kirsten Newquist, Identiv’s CEO, and Mark Sawicki, PhD, Cryoport Systems’ president and CEO, explain how embedded product intelligence—paired with cautious, strategic adoption of AI—is redefining pharmaceutical cold chain reliability and supply-chain decision-making.

Why AI Advances in CGT Require Getting Data Right

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

Stop Losing Patients at the Gate: The 24-Hour Window That Makes or Breaks Your Entire Hub Program

Point of Care Lifts Reps Efforts

Point of Care and PatientPoint can improve the impact that your Pharma Reps are already having.

From Data Overload to Intelligent Commercialization: How Pharma Can Turn Connection Into Competitive Advantage

When intelligence flows across clinical, access, and engagement channels, commercialization shifts from reactive to predictive, giving teams the real-time edge to win in a fast-moving market.

The End of the Traditional Launch: How JCA, HTA Evolution and Pricing Pressures Are Driving Continuous Evidence Generation

Joint clinical assessment, shifting HTA demands and pricing pressure are making launch the start of continuous evidence generation.

Understanding Supply Chain Constraints to Enable Growth for Cell & Gene Therapies

Krystal Haynes, Senior Director of Business Development, ICS, at Cencora, outlines the challenges facing cell and gene therapy manufacturers as they attempt to move products from clinical development to commercial availability.

DSCSA Compliance: Milestones, More Deadlines—and the Road Ahead

Advice for pharma distributors and dispensers on what they should do now in order to solidify a secure supply chain.

Why Account Teams Call ClaimGuardRx Their Smartest Teammate

Logan Melchione shares how ClaimGuardRx gives account teams a fast, conversational way to tackle diversion and fraud together, and what that means for clients and patients.

Monitoring Payer-Level Performance and Planning

Payer-level reporting should do more than track performance—it must guide strategy, focus resources, and drive measurable brand impact.

Fair Market Value vs. Current Market Leverage

How pharmaceutical manufacturers should consider their Fair Market Value cost assessment compared to their negotiation leverage when contracting for distribution services

Why Pharmaceutical Products Need Sustainable Packaging

One packaging aspect—the tape—is often overlooked, but is a valuable component of the shipping process.

Innovation with GenAI: Lessons from Life Sciences and Beyond

By embracing practical, human-centered use cases, life sciences companies are breaking free from GenAI “pilotitis” and demonstrating how scalable AI solutions can help transform patient care and provider efficiency.

Moving from Omnichannel to Optichannel Engagement Strategies: Your Questions Answered

Why the life science industry needs to move away from omnichannel marketing strategies and toward optichannel approaches that boost personalization and ROI in an era of shrinking budgets.

AI-Fueled Counterfeiting Surges as Pharma Confronts Rising Digital Threats

In a video interview with Pharma Commerce, Mark Lee, Marqvision’s founder and CEO, and Sean O’Hearen, founder and principal consultant at 1st Line Partners, warn that counterfeiters are rapidly leveraging AI to create fake websites, social profiles, and manipulated product content—outpacing traditional protections and highlighting widespread underreporting of falsified medicines.

Innovation with GenAI: Lessons from Life Sciences and Beyond

By embracing practical, human-centered use cases, life sciences companies are breaking free from GenAI “pilotitis” and demonstrating how scalable AI solutions can help transform patient care and provider efficiency.

End-to-End Commercialization Guide

Two Labs and Riparian, both part of Envision Pharma Group, work alongside specialty pharma manufacturers at nearly every stage of commercialization — government pricing and compliance, patient support programs, specialty pharmacy selection, trade and distribution, and post-launch optimization. Each chapter of this guide was written by the experts who lead that work, drawing on real conversations with manufacturers navigating these decisions.

Streamlining Clinical Trials with Site Augmentation

Imagine a world where clinical trials move seamlessly from concept to completion, staffing shortages are a thing of the past and patient recruitment happens at a record speed. Join Marken’s patient centric solutions expert and our featured guest for a dynamic discussion on how customizable site augmentation programs are accelerating life-saving treatments to market faster through scalable, flexible decentralized strategies. Learn practical solutions for streamlining on-site, remote or hybrid trials by matching dedicated clinical research professionals to your site’s unique needs, relieving staff burdens and empowering your team to focus on what matters most – patient care.

How Organizations Can Build a True Culture of Compliance

In final part of his Pharma Commerce video interview, Faisal Khan, a GRC solutions expert with Vanta, points out how leadership buy-in, role-based training, and “cyber moments” can reinforce continuous awareness and shared responsibility across the organization.